Why do patients with low-grade soft tissue sarcoma die?

Area of Science:

• Oncology
• Surgical Pathology
• Sarcoma Research

Background:

• Patterns of failure and mechanisms of sarcoma-specific death are poorly understood in low-grade soft tissue sarcoma (STS).
• A minority of patients with low-grade STS succumb to their disease, necessitating a clearer understanding of their failure patterns.

Purpose of the Study:

• To characterize the patterns of failure and mechanisms of sarcoma-specific death in a large cohort of patients with low-grade soft tissue sarcoma (STS).
• To identify significant risk factors associated with disease-specific death (DOD), death from locally recurrent disease (DOLR), and death from distant recurrent disease (DODR).

Main Methods:

• A prospective follow-up study of 2,041 patients aged 16 years or older with low-grade STS treated with curative intent between 1982 and 2006.
• Multivariate analysis was employed to identify factors associated with DOD, DOLR, and DODR.

Main Results:

• Approximately 9% (181/2041) of patients died from disease (DOD).
• Locally recurrent disease (DOLR) was the primary cause of death in 58% of DOD cases, while distant disease (DODR) accounted for 32%.
• Significant risk factors for DOD included non-extremity tumor site, larger size, and less than R0 resection. Distinct patterns of recurrence and death were predicted by primary tumor site.

Conclusions:

• Low-grade STS results in disease-specific death in approximately 9% of patients.
• Non-extremity site, larger tumor size, and incomplete resection (less than R0) are critical risk factors for DOD in low-grade STS.
• Primary tumor site significantly influences patterns of recurrence and subsequent death.